$467,469
Chief Scientific Officer/Interim CEO
2021
$411k org
40 hrs/wk
$57k other
--
Chief Scientific Officer/Interim CEO at The Mark Foundation for Cancer Research (US) Ltd.
Fiscal year ended December 31, 2021. Published on January 25, 2026.
Total compensation
Ryan Schoenfield has been listed as an employee of The Mark Foundation for Cancer Research (US) Ltd. in Form 990 filings since fiscal year 2021.